NeuroOne Medical Technologies Corp
NMTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.58M
Close$
$-1.04
166.6% downside
Current Fair Value
166.6% downsideOvervalued by 166.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.58 Million |
|---|---|
| Enterprise Value | $11.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.64 |
| Outstanding Shares | 8,661,624 |
Return
| Return on Equity | -189.76% |
|---|---|
| Return on Assets | -115.57% |
| Return on Invested Capital | -199.53% |
Valuation & Multiples
| P/E Ratio | -1.71 |
|---|---|
| PEG | -5.07 |
| Price to Sales | 1.56 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -1.4 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.97 M
Average shareholder expectationNext Earnings Call
Expected Date
December 15, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$2.79 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.60%▲ 0.33% |
|---|---|
| Total Invested | $6.21M▼ 32.05% |
| Investors Holding | 27▼ 5.00% |
ESG Score
No data
About NeuroOne Medical Technologies Corp
2,019 employees